<ddi:DDIInstance xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="ddi:instance:3_3 http://ddialliance.org/Specification/DDI-Lifecycle/3.3/XMLSchema/instance.xsd" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ddi="ddi:instance:3_3" xmlns:r="ddi:reusable:3_3" xmlns:s="ddi:studyunit:3_3" xmlns:d="ddi:datacollection:3_3" xmlns:a="ddi:archive:3_3" xmlns:c="ddi:conceptualcomponent:3_3" xmlns:cm="ddi:comparative:3_3" xmlns:g="ddi:group:3_3" xmlns:l="ddi:logicalproduct:3_3" xmlns:p="ddi:physicaldataproduct:3_3" xmlns:pi="ddi:physicalinstance:3_3" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:xml="http://www.w3.org/XML/1998/namespace" isMaintainable="true" scopeOfUniqueness="Agency">
  <r:URN>urn:ddi:se.researchdata:2023-80-1:1</r:URN>
  <r:Agency>SND</r:Agency>
  <r:ID>2023-80-1</r:ID>
  <r:Version>1</r:Version>
  <g:ResourcePackage>
    <r:URN>urn:ddi:se.researchdata:2023-80-1.ResourcePackage:2.0</r:URN>
    <r:OtherMaterialScheme>
      <r:URN>urn:ddi:se.researchdata:2023-80-1.OtherMaterialScheme:2.0</r:URN>
    </r:OtherMaterialScheme>
    <a:OrganizationScheme>
      <r:URN>urn:ddi:se.researchdata:2023-80-1.OrganizationScheme-0:2.0</r:URN>
      <a:Individual>
        <r:URN>urn:ddi:se.researchdata:2023-80-1.Individual-0:2.0</r:URN>
        <r:UserAttributePair>
          <r:AttributeKey>affiliation</r:AttributeKey>
          <r:AttributeValue>Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg</r:AttributeValue>
        </r:UserAttributePair>
        <a:IndividualIdentification>
          <a:IndividualName>
            <a:FirstGiven>Victoria</a:FirstGiven>
            <a:LastFamily>Rotter Sopasakis</a:LastFamily>
            <a:FullName>
              <r:String>Victoria Rotter Sopasakis</r:String>
            </a:FullName>
          </a:IndividualName>
          <a:ResearcherID>
            <a:TypeOfID>ORCID</a:TypeOfID>
            <a:ResearcherIdentification>0000-0002-1012-1952</a:ResearcherIdentification>
          </a:ResearcherID>
        </a:IndividualIdentification>
      </a:Individual>
      <a:Individual>
        <r:URN>urn:ddi:se.researchdata:2023-80-1.Individual-0:2.0</r:URN>
        <r:UserAttributePair>
          <r:AttributeKey>affiliation</r:AttributeKey>
          <r:AttributeValue>Department of Laboratory Medicine, Institute of Biomedicine, University of Gothenburg</r:AttributeValue>
        </r:UserAttributePair>
        <a:IndividualIdentification>
          <a:IndividualName>
            <a:FirstGiven>Lillemor</a:FirstGiven>
            <a:LastFamily>Mattsson Hultén</a:LastFamily>
            <a:FullName>
              <r:String>Lillemor Mattsson Hultén</r:String>
            </a:FullName>
          </a:IndividualName>
          <a:ResearcherID>
            <a:TypeOfID>ORCID</a:TypeOfID>
            <a:ResearcherIdentification>0000-0003-1273-3466</a:ResearcherIdentification>
          </a:ResearcherID>
        </a:IndividualIdentification>
      </a:Individual>
    </a:OrganizationScheme>
  </g:ResourcePackage>
  <s:StudyUnit>
    <r:URN>urn:ddi:se.researchdata:2023-80-1.StudyUnit:2.0</r:URN>
    <r:UserID typeOfUserID="datasetIdentifier">2023-80-1</r:UserID>
    <r:Citation>
      <r:Title>
        <r:String xml:lang="sv">RNA-sekvenseringsdata från patienter med hjärtsjukdom och kontroller</r:String>
        <r:String xml:lang="en">RNA sequencing data from patients with heart disease and controls</r:String>
      </r:Title>
      <r:Creator>
        <r:CreatorReference>
          <r:URN>urn:ddi:se.researchdata:2023-80-1.Individual-0:2.0</r:URN>
          <r:TypeOfObject>Individual</r:TypeOfObject>
        </r:CreatorReference>
      </r:Creator>
      <r:Publisher>
        <r:PublisherName>
          <r:String xml:lang="sv">Göteborgs universitet</r:String>
          <r:String xml:lang="en">University of Gothenburg</r:String>
        </r:PublisherName>
      </r:Publisher>
      <r:Publisher>
        <r:PublisherName>
          <r:String xml:lang="sv">Göteborgs universitet</r:String>
          <r:String xml:lang="en">University of Gothenburg</r:String>
        </r:PublisherName>
      </r:Publisher>
      <r:PublicationDate>
        <r:SimpleDate>2023-04-17</r:SimpleDate>
      </r:PublicationDate>
      <r:InternationalIdentifier>
        <r:IdentifierContent>10.5878/e48r-gn02</r:IdentifierContent>
        <r:ManagingAgency controlledVocabularyAgencyName="DOI">DOI</r:ManagingAgency>
      </r:InternationalIdentifier>
    </r:Citation>
    <r:Abstract>
      <r:Content xml:lang="sv">Data i denna studie kommer från RNA-sekvenseringsanalys av förmaksvävnad från humana hjärtan från patienter som genomgick coronary artery bypass grafting (CABG) eller aortic valve replacement (AVR) samt förmaksvävnad från organdonatorer (kontroller) och inköpt humant RNA från förmaksvävnad (kontroller).</r:Content>
      <r:Content xml:lang="en">RNA sequencing analysis of atrial cardiac tissue from patients undergoing coronary artery bypass grafting (CABG) or aortic valve replacement (AVR) was performed and compared with atrial cardiac tissue from organ donors and purchased human atrial cardiac RNA. 

RNA sequencing analysis was performed at the Genomics Core Facility at University of Gothenburg, Sweden. All samples (ten controls, ten CABG patients and ten AVR patients) were quality checked by the RNA integrity number (RIN) using Tapestation 2200 RNA screenTape (Agilent Technologies, Santa Clara, CA) and RNA concentration was measured by NanoDrop (Thermo Fisher, Waltham, MA). RIN values ranged between 6.6 and 9.0 for all samples. TruSeq Total Stranded RNA kit with RiboZero (Gold) Sample Preparation Guide (15,031,048 Rev. E) was used for RNA sample preparation (Illumina, San Diego, CA). A total of 10 μl (~1 μg) RNA from each sample was used for library preparation. Directly after depletion, a cleanup step was performed using 110 ul of the RNAClean XP beads (Beckman Coulter, USA) for each sample. The fragmentation step was performed for 8 min. 12 PCR cycles were run for all samples. Libraries were quantified and normalized with Qubit DNA HS Assay kit (Life Technologies, Carlsbad, CA) and fragment size determined by Tapestation 2200 (Agilent Technologies, Santa Clara, CA). The libraries were pooled together by using the Illumina protocol for pooling and sequenced with NovaSeq 6000 S1 (Illumina, San Diego, CA) for the read length of 2 × 100 bp.</r:Content>
    </r:Abstract>
    <r:Coverage>
      <r:TopicalCoverage>
        <r:URN>urn:ddi:se.researchdata:2023-80-1.TopicalCoverage:2.0</r:URN>
        <r:Subject xml:lang="en" controlledVocabularyID="10609" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Genetics and Genomics</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="10609" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Genetik och genomik</r:Subject>
        <r:Subject xml:lang="en" controlledVocabularyID="10610" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Bioinformatics and Computational Biology</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="10610" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Bioinformatik och beräkningsbiologi</r:Subject>
        <r:Subject xml:lang="en" controlledVocabularyID="301" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Basic Medicine</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="301" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Medicinska och farmaceutiska grundvetenskaper</r:Subject>
        <r:Subject xml:lang="en" controlledVocabularyID="30107" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Medical Genetics and Genomics</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="30107" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Medicinsk genetik och genomik</r:Subject>
        <r:Subject xml:lang="en" controlledVocabularyID="30108" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Cell and Molecular Biology</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="30108" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Cell- och molekylärbiologi</r:Subject>
        <r:Subject xml:lang="en" controlledVocabularyID="30206" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Cardiology and Cardiovascular Disease</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="30206" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Kardiologi och kardiovaskulära sjukdomar</r:Subject>
        <r:Subject xml:lang="en" controlledVocabularyID="10616" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Molecular Biology</r:Subject>
        <r:Subject xml:lang="sv" controlledVocabularyID="10616" controlledVocabularyName="Standard för svensk indelning av forskningsämnen 2025">Molekylärbiologi</r:Subject>
        <r:Keyword xml:lang="en" controlledVocabularyID="D006331" controlledVocabularyName="MeSH">Heart Diseases</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D006331" controlledVocabularyName="MeSH">Hjärtsjukdomar</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D001021" controlledVocabularyName="MeSH">Aortic Valve</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D001021" controlledVocabularyName="MeSH">Aortaklaff</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D001026" controlledVocabularyName="MeSH">Coronary Artery Bypass</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D001026" controlledVocabularyName="MeSH">Koronar bypass</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D015820" controlledVocabularyName="MeSH">Cadherins</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D015820" controlledVocabularyName="MeSH">Kadheriner</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D019918" controlledVocabularyName="MeSH">Heart Valve Prosthesis Implantation</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D019918" controlledVocabularyName="MeSH">Hjärtklaffprotesimplantation</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D062085" controlledVocabularyName="MeSH">RNA, Long Noncoding</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D062085" controlledVocabularyName="MeSH">Långt icke-kodande RNA</r:Keyword>
        <r:Keyword xml:lang="en" controlledVocabularyID="D000070585" controlledVocabularyName="MeSH">Cadherin Related Proteins</r:Keyword>
        <r:Keyword xml:lang="sv" controlledVocabularyID="D000070585" controlledVocabularyName="MeSH">Kadherinrelaterade proteiner</r:Keyword>
      </r:TopicalCoverage>
      <r:SpatialCoverage>
        <r:URN>urn:ddi:se.researchdata:2023-80-1.SpatialCoverage:2.0</r:URN>
        <r:CountryCode>SE</r:CountryCode>
      </r:SpatialCoverage>
    </r:Coverage>
    <r:AnalysisUnit controlledVocabularyID="AnalysisUnit" controlledVocabularyAgencyName="DDI Alliance">Individual<r:ControlledVocabularyURN>http://rdf-vocabulary.ddialliance.org/cv/AnalysisUnit/2.1.3/2dd4472</r:ControlledVocabularyURN></r:AnalysisUnit>
    <r:AnalysisUnitsCovered>
      <r:String xml:lang="en">Individual</r:String>
      <r:String xml:lang="sv">Individ</r:String>
    </r:AnalysisUnitsCovered>
    <a:Archive>
      <r:URN>urn:ddi:se.researchdata:2023-80-1.Archive:2.0</r:URN>
      <a:ArchiveSpecific>
        <a:Item>
          <a:Access>
            <r:URN>urn:ddi:se.researchdata:2023-80-1.Archive-ArchiveSpecificType-AccessType:2.0</r:URN>
            <a:TypeOfAccess controlledVocabularyName="info:eu-repo-Access-Terms vocabulary">restrictedAccess</a:TypeOfAccess>
          </a:Access>
          <a:DataFileQuantity>0</a:DataFileQuantity>
        </a:Item>
      </a:ArchiveSpecific>
    </a:Archive>
  </s:StudyUnit>
</ddi:DDIInstance>